US Influenza Diagnostics Market Size study, by Test Type (RIDT, RT-PCR, Cell Culture, Others), by End Use (Hospitals, POCT, Laboratories) Forecasts 2022-2032
US Influenza Diagnostics Market is valued at approximately USD 371.47 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.86 % over the forecast period 2024-2032. Influenza diagnostics encompass the range of methods and tools employed for identifying and diagnosing influenza virus infections in individuals. These diagnostic measures are pivotal in public health, enabling timely detection, treatment, and containment of influenza outbreaks. Also, Artificial Intelligence (AI) and data analytics are being integrated into influenza diagnostics to enhance accuracy, streamline workflows, and improve predictive capabilities. These technologies can analyze vast amounts of data to identify patterns and predict future outbreaks which anticipated to support the growth of Influenza Diagnostics Market.
Moreover, public awareness regarding the importance of early diagnosis and treatment of influenza has been rising. This awareness, coupled with concerns about pandemics and the potential severity of influenza-related complications, drives the demand for diagnostic tests. Also, cohesive government initiatives aimed at controlling the spread of influenza, such as vaccination campaigns and funding for research and development, contribute to market growth. Policies promoting the use of diagnostic tests for surveillance and control further drive market expansion. Additionally, other factors that support the market growth are the increasing geriatric population, growing demand for point-of-care testing, and cohesive government initiatives and funding. However, the lack of skilled professionals and stringent regulatory frameworks are anticipated to hinder the market growth during the forecast period 2024-2032.
Major market player included in this report are:
Hologic, Inc.
Abbott Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
Moreover, public awareness regarding the importance of early diagnosis and treatment of influenza has been rising. This awareness, coupled with concerns about pandemics and the potential severity of influenza-related complications, drives the demand for diagnostic tests. Also, cohesive government initiatives aimed at controlling the spread of influenza, such as vaccination campaigns and funding for research and development, contribute to market growth. Policies promoting the use of diagnostic tests for surveillance and control further drive market expansion. Additionally, other factors that support the market growth are the increasing geriatric population, growing demand for point-of-care testing, and cohesive government initiatives and funding. However, the lack of skilled professionals and stringent regulatory frameworks are anticipated to hinder the market growth during the forecast period 2024-2032.
Major market player included in this report are:
Hologic, Inc.
Abbott Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. US INFLUENZA DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Test Type
2.2.2. By End Use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. US INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Hologic, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Abbott Laboratories, Inc.
7.3.3. Thermo Fisher Scientific, Inc.
7.3.4. Becton, Dickinson and Company
7.3.5. Company
7.3.6. Company
7.3.7. Company
7.3.8. Company
7.3.9. Company
7.3.10. Company
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Test Type
2.2.2. By End Use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. US INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Hologic, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Abbott Laboratories, Inc.
7.3.3. Thermo Fisher Scientific, Inc.
7.3.4. Becton, Dickinson and Company
7.3.5. Company
7.3.6. Company
7.3.7. Company
7.3.8. Company
7.3.9. Company
7.3.10. Company
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
LIST OF TABLES
TABLE 1. US Influenza Diagnostics market, report scope
TABLE 2. US Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 3. US Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 4. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 5. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. U.S. Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 11. U.S. Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. List of secondary sources, used in the study of US Influenza Diagnostics Market.
TABLE 13. List of primary sources, used in the study of US Influenza Diagnostics Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
TABLE 1. US Influenza Diagnostics market, report scope
TABLE 2. US Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 3. US Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 4. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 5. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. U.S. Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 11. U.S. Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. List of secondary sources, used in the study of US Influenza Diagnostics Market.
TABLE 13. List of primary sources, used in the study of US Influenza Diagnostics Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
LIST OF FIGURES
FIG 1. US Influenza Diagnostics market, research methodology
FIG 2. US Influenza Diagnostics market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Influenza Diagnostics market, key trends 2023
FIG 5. US Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. US Influenza Diagnostics market, porters 5 force model
FIG 7. US Influenza Diagnostics market, pestel analysis
FIG 8. US Influenza Diagnostics market, value chain analysis
FIG 9. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. US Influenza Diagnostics market, company market share analysis (2023)
FIG 1. US Influenza Diagnostics market, research methodology
FIG 2. US Influenza Diagnostics market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Influenza Diagnostics market, key trends 2023
FIG 5. US Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. US Influenza Diagnostics market, porters 5 force model
FIG 7. US Influenza Diagnostics market, pestel analysis
FIG 8. US Influenza Diagnostics market, value chain analysis
FIG 9. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. US Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. US Influenza Diagnostics market, company market share analysis (2023)
